IRWD - Ironwood Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 51.56B
Enterprise Value 31.85B
Trailing P/E 71.52
Forward P/E 116.18
PEG Ratio (5 yr expected) 10.25
Price/Sales (ttm)3.64
Price/Book (mrq)N/A
Enterprise Value/Revenue 34.32
Enterprise Value/EBITDA 614.34

Trading Information

Stock Price History

Beta (5Y Monthly) 1.76
52-Week Change 3-22.04%
S&P500 52-Week Change 3-14.20%
52 Week High 314.10
52 Week Low 37.91
50-Day Moving Average 310.98
200-Day Moving Average 311.20

Share Statistics

Avg Vol (3 month) 32.04M
Avg Vol (10 day) 31.94M
Shares Outstanding 5156.82M
Float 141.69M
% Held by Insiders 12.94%
% Held by Institutions 1117.51%
Shares Short (Mar 12, 2020) 428M
Short Ratio (Mar 12, 2020) 411.67
Short % of Float (Mar 12, 2020) 421.09%
Short % of Shares Outstanding (Mar 12, 2020) 417.70%
Shares Short (prior month Feb 13, 2020) 428.71M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21194:1000
Last Split Date 3Apr 01, 2019

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2019
Most Recent Quarter (mrq)Dec 30, 2019


Profit Margin 5.02%
Operating Margin (ttm)28.82%

Management Effectiveness

Return on Assets (ttm)21.00%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)428.41M
Revenue Per Share (ttm)2.75
Quarterly Revenue Growth (yoy)-3.40%
Gross Profit (ttm)293.02M
EBITDA 129.05M
Net Income Avi to Common (ttm)58.94M
Diluted EPS (ttm)0.14
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)177.02M
Total Cash Per Share (mrq)1.12
Total Debt (mrq)431.22M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)7.50
Book Value Per Share (mrq)-0.59

Cash Flow Statement

Operating Cash Flow (ttm)10.72M
Levered Free Cash Flow (ttm)15.28M